Login / Signup

Recent advances in transmission-blocking drugs for malaria elimination.

Ishan WadiMahendra NathAnupkumar R AnvikarPargat SinghAbhinav Sinha
Published in: Future medicinal chemistry (2019)
The scientific community worldwide has realized that malaria elimination will not be possible without development of safe and effective transmission-blocking interventions. Primaquine, the only WHO recommended transmission-blocking drug, is not extensively utilized because of the toxicity issues in G6PD deficient individuals. Therefore, there is an urgent need to develop novel therapeutic interventions that can target malaria parasites and effectively block transmission. But at first, it is imperative to unravel the existing portfolio of transmission-blocking drugs. This review highlights transmission-blocking potential of current antimalarial drugs and drugs that are in various stages of clinical development. The collective analysis of the relationships between the structure and the activity of transmission-blocking drugs is expected to help in the design of new transmission-blocking antimalarials.
Keyphrases
  • plasmodium falciparum
  • physical activity
  • emergency department
  • oxidative stress
  • wild type